Navigation Links
Texas on Top of Cancer Research: Dallas Regional Chamber Hosts Forum on New $3 Billion Fund
Date:7/30/2009

tp://www.dallastbc.org/" target="_new">www.DallasTBC.org. The cost to attend is $40 for TBC Investors, $45 for Chamber Members, and $60 for General Admission.

Event sponsors include the Baylor Research Institute, Jones Day and The University of North Texas.

To register or for more information, call 214-712-1937.

The Chamber's Technology Business Council's mission is to develop, promote and sustain the Dallas/Fort Worth region as a global leader in technology talent, innovation, integration and manufacturing. 

    Contact: Lauren Parsons
    Director, Communications
    Direct Line: 214-746-6690
    lparsons@dallaschamber.org


'/>"/>
SOURCE Dallas Regional Chamber
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Texas Supreme Court Rules Against Medicare HMOs in Hospital Reimbursement Fight
2. Texas Largest Physician Carrier Announces 5th Successive Rate Cut on Anniversary of Lawsuit Reform
3. University of Texas Study Details Lengthy Payment Delays for Medicare Part D Prescription Drug Claims, Confirming Need for Legislative Fix
4. South Texas Doctors Report More Severe Cases of Community Staph Super Bug Hospitalizing Children
5. Texas Aviation Services: Over 20 Years of Creating Flying Emergency Rooms for Airborne EMS Customers in US and Latin America
6. Dermatologists identify North Texas leishmaniasis outbreak
7. Precedent Launches Revolutionary Individual Health Insurance Plans in Texas
8. Health Care Service Corporation Provides Personal Clinical Summaries to Members of its Blue Cross and Blue Shield plans in Illinois, New Mexico, Oklahoma and Texas
9. Sesame Street Exhibition Makes Texas Premier at The Health Museum
10. The Law Offices of John David Hart: Texas Man Sues Medtronic in Body-Snatching Case
11. Viant Acquires Texas True Choice
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/15/2010)... that may help fill a critical need in stem ... School of Medicine have demonstrated that skin cells found ... pluripotency, where they have characteristics similar to human embryonic ... of cell in the human body. The study is ... next issue of the journal Cellular Reprogramming , ...
(Date:3/15/2010)... Normal individuals who scored high on a measure of ... to a brain imaging study by researchers at Vanderbilt ... in the brain,s reward system that may underlie vulnerability ... study in the current issue of the journal ... on Drug Abuse (NIDA), a component of the National ...
(Date:3/15/2010)... BRUNSWICK, N.J. , March 15 ... statewide female-specific AIDS service organization, has launched "I Stand ... intended to mobilize families, individuals, corporations, social service agencies, ... up for the lives of women in NJ. At ... proportion of women living with AIDS in the nation. ...
(Date:3/15/2010)... [NLA] was recently featured by Lloyd,s of London in their electronic market ... insurance market. The article featuring New Life was in response to the recent press ... introduce the nations first in vitro fertilization insurance program. , ... ... , ...
(Date:3/15/2010)... Fla. (March 15, 2010)Patient selection is key ... interventional radiologists in individuals with painful osteoporotic ... to conventional medical therapyto be effective and ... than 1,500 persons who were followed over ... radiologist and other medical experts in treating ...
Breaking Medicine News(10 mins):Health News:Amniotic fluid cells more efficiently reprogrammed to pluripotency than adult cells 2Health News:Amniotic fluid cells more efficiently reprogrammed to pluripotency than adult cells 3Health News:Impulsive-antisocial personality traits linked to a hypersensitive brain reward system 2Health News:Impulsive-antisocial personality traits linked to a hypersensitive brain reward system 3Health News:For Women's History Month New Jersey Women and AIDS Network Launches 'I Stand With NJWAN' HIV Action and Awareness Campaign 2Health News:For Women's History Month New Jersey Women and AIDS Network Launches 'I Stand With NJWAN' HIV Action and Awareness Campaign 3Health News:Lloyd's of London News Features New Life Agency, Inc. 2Health News:Lloyd's of London News Features New Life Agency, Inc. 3Health News:Vertebroplasty for patients with osteoporosis provides effective pain relief 2Health News:Vertebroplasty for patients with osteoporosis provides effective pain relief 3
... teens. A report also disclosed that the recent sharp increases ... use decreased, and a gradual decline in use of inhalants ... ,These important declines in teen smoking did not ... have been making concerted efforts to bring down the unacceptably ...
... ensure the best outcome for the patient. This should ... avoid the side effects relating to these drugs. Several ... at Texas University it is necessary to find out ... differences between these drugs when it comes to reducing ...
... ‘Cyber City’ in Hyderabad, Andhra Pradesh chief minister Chandrababu ... up a ‘Pharma City’ in the port town of ... the state government hopes to attract global pharmaceutical companies ... the post-patent regime by 2005. The ‘Pharma City’ will ...
... to French researchers there is no obvious medical explanation ... patients during cardiac arrest. The near death experience (NDE) ... years.// It involves a feeling of disconnection from the ... cardiac arrest - and often progress down a tunnel ...
... demand for a new vaccine against childhood pneumonia, meningitis ... the country. Meanwhile, doctors are directing the supplies they ... of infection, such as those with sickle cell anemia, ... immune system. ,PREVNAR fights the bacterium streptococcus pneumoniae, ...
... despite a diet rich in butter and other fats, has ... another staple of the French diet. //Scientists say they have ... pigments known as polyphenols. ,Polyphenols inhibit the ... arteries. Polyphenols in red wine decreases the amount of the ...
Other Medicine News:
(Date:3/15/2010)... ATLANTA , March 15 ... (HFMA) InstaPoll, a majority of hospitals believe they ... chargeable supplies. With pending healthcare reforms and proposed ... face increased demands from the government and patients ... with less. As healthcare organizations look for ways ...
(Date:3/15/2010)... March 15 A new ... rates in patients with a common genetic variant ... TRITON-TIMI 38 study were treated with dual antiplatelet ... Effient® (prasugrel) plus aspirin and managed with percutaneous ... (ACS) event. The results of this retrospective genetic sub-study ...
(Date:3/15/2010)... At this year,s annual meeting ... March 14-16 in Atlanta ... PHI) will showcase its commitment to simplifying ... of technology advancements.  These care innovations span ... systems, new temperature modulation therapies, solutions that ...
Breaking Medicine Technology:Craneware-Sponsored Panel to Focus on Preventing Revenue Leakage for Chargeable Supplies 2Craneware-Sponsored Panel to Focus on Preventing Revenue Leakage for Chargeable Supplies 3Craneware-Sponsored Panel to Focus on Preventing Revenue Leakage for Chargeable Supplies 4Craneware-Sponsored Panel to Focus on Preventing Revenue Leakage for Chargeable Supplies 5New Analysis Assesses Impact of Common Genetic Variation on Benefit of Antiplatelet Therapy 2New Analysis Assesses Impact of Common Genetic Variation on Benefit of Antiplatelet Therapy 3New Analysis Assesses Impact of Common Genetic Variation on Benefit of Antiplatelet Therapy 4New Analysis Assesses Impact of Common Genetic Variation on Benefit of Antiplatelet Therapy 5New Analysis Assesses Impact of Common Genetic Variation on Benefit of Antiplatelet Therapy 6New Analysis Assesses Impact of Common Genetic Variation on Benefit of Antiplatelet Therapy 7New Analysis Assesses Impact of Common Genetic Variation on Benefit of Antiplatelet Therapy 8New Analysis Assesses Impact of Common Genetic Variation on Benefit of Antiplatelet Therapy 9New Analysis Assesses Impact of Common Genetic Variation on Benefit of Antiplatelet Therapy 10New Analysis Assesses Impact of Common Genetic Variation on Benefit of Antiplatelet Therapy 11Philips Simplifies Cardiology Care With Technologies That Span the Entire Spectrum of Patient Care 2Philips Simplifies Cardiology Care With Technologies That Span the Entire Spectrum of Patient Care 3Philips Simplifies Cardiology Care With Technologies That Span the Entire Spectrum of Patient Care 4Philips Simplifies Cardiology Care With Technologies That Span the Entire Spectrum of Patient Care 5Philips Simplifies Cardiology Care With Technologies That Span the Entire Spectrum of Patient Care 6Philips Simplifies Cardiology Care With Technologies That Span the Entire Spectrum of Patient Care 7Philips Simplifies Cardiology Care With Technologies That Span the Entire Spectrum of Patient Care 8Philips Simplifies Cardiology Care With Technologies That Span the Entire Spectrum of Patient Care 9Purple Communications 28TM 29 Announces Second Quarter 2009 Results 54538 1Purple Communications 28TM 29 Announces Second Quarter 2009 Results 54538 2Purple Communications 28TM 29 Announces Second Quarter 2009 Results 54538 3Purple Communications 28TM 29 Announces Second Quarter 2009 Results 54538 4Purple Communications 28TM 29 Announces Second Quarter 2009 Results 54538 5Purple Communications 28TM 29 Announces Second Quarter 2009 Results 54538 6Purple Communications 28TM 29 Announces Second Quarter 2009 Results 54538 7Purple Communications 28TM 29 Announces Second Quarter 2009 Results 54538 8Device May Offer Alternative to Warfarin for Arrhythmia 54533 1Device May Offer Alternative to Warfarin for Arrhythmia 54533 2TeamStaff Reports Third Quarter Results 54528 1TeamStaff Reports Third Quarter Results 54528 2TeamStaff Reports Third Quarter Results 54528 3TeamStaff Reports Third Quarter Results 54528 4TeamStaff Reports Third Quarter Results 54528 5TeamStaff Reports Third Quarter Results 54528 6TeamStaff Reports Third Quarter Results 54528 7TeamStaff Reports Third Quarter Results 54528 8TeamStaff Reports Third Quarter Results 54528 9TeamStaff Reports Third Quarter Results 54528 10TeamStaff Reports Third Quarter Results 54528 11TeamStaff Reports Third Quarter Results 54528 12TeamStaff Reports Third Quarter Results 54528 13TeamStaff Reports Third Quarter Results 54528 14
... COLLEGEVILLE, Pa., May 23 Wyeth Pharmaceuticals, a,division ... that the U.S. Food and Drug,Administration (FDA) issued ... selective estrogen receptor modulator, for the treatment of,postmenopausal ... to that outlined in its approvable letter for ...
... 22 Epeius Biotechnologies,announced today the promising results of ... metastatic breast cancer that is refractory,to conventional chemotherapy (J ... of Rexin-G given i.v. two to,three times a week ... 10e11 cfu to 6,x 10e11 cfu per week. The ...
Other Medicine Technology:Wyeth Receives Approvable Letter From FDA for Bazedoxifene for the Treatment of Postmenopausal Osteoporosis 2Wyeth Receives Approvable Letter From FDA for Bazedoxifene for the Treatment of Postmenopausal Osteoporosis 3TARGETED GENE DELIVERY IN VIVO: Rexin-G Monotherapy Reveals Significant Biological Activity Without Toxicity in Chemo-Resistant Metastatic Breast Cancer (ASCO 2008) 2
Natural-looking colors for dark eyes....
Dot matrix pattern for light eyed patients....
An entirely new way to brighten and enhance natural eye color....
Enhances the eye color of light-eyed patients....
Medicine Products: